34
Participants
Start Date
December 8, 2022
Primary Completion Date
October 31, 2025
Study Completion Date
December 31, 2025
BAX602
Consists of the spray agent, spray set, and spraying device (regulator). Dissolves a polyethylene glycol (PEG) derivative with an N-hydroxysuccinimide group at the end (COH102) and a PEG derivative with a thiol group (COH206) as an anti-adhesion agent, which is sprayed on the surgical surface to reduce the degree, frequency, and extent of organ adhesions after surgery.
No Intervention
Control Group
Nagano Children's Hospital, Azumino
Hyogo Prefectural Kobe Children's Hospital, Kobe
Aichi Children's Hospital and Medical Center, Ōbu
Fukuoka Children's Hospital, Fukuoka
Okayama University Hospital, Okayama
Shizuoka Children's Hospital, Shizuoka
Baxter Healthcare Corporation
INDUSTRY